RIPK3 and neoplasm: In addition, RIPK3 can participate in tumorigenesis by (1) acting on various T cells to enhance cellular immunity; (2) inducing the aggregation of immunosuppressive myeloid cells, including myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), to promote immune evasion of cancer cells; (3) participating in PANoptosis.